SCHEMBL19127012

SCHEMBL19127012

O=C(O)c1ccc(-n2cc(-c3cc4cc(F)ccc4[nH]c3=O)nn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 2/20 0.46
▸ PIK3CA P42336 1/20 0.44
▸ CSNK1D P48730 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ CDK5 Q00535 1/20 0.43
▸ CDK5R1 Q15078 1/20 0.43
▸ TDP1 Q9NUW8 2/20 0.41
▸ PDPK1 O15530 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ APEX1 P27695 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19127082 0.91 KDM4E (0.43) MAPK14PIK3CACSNK1DKDM4EALDH1A1
SCHEMBL19145729 0.88 DAO (0.47) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL19127238 0.88 DHODH (0.47) MAPK14KDM4EALDH1A1MAPTNPC1
SCHEMBL19126803 0.88 KDM4E (0.41) MAPK14PIK3CACSNK1DKDM4EALDH1A1
SCHEMBL19127086 0.86 KDR (0.48) MAPK14PIK3CAKDM4EALDH1A1MAPT
SCHEMBL19126371 0.86 KDR (0.48) MAPK14PIK3CAKDM4EALDH1A1MAPT
SCHEMBL19145552 0.86 KDR (0.48) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL19145221 0.86 KDR (0.49) MAPK14KDM4EALDH1A1MAPTNPC1
SCHEMBL22110441 0.85 CDK5 (0.45) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL19145218 0.85 KDR (0.52) MAPK14KDM4EALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939314-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2024-03-26 — — US disclosed
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
EP-3402792-A1 QUINOLIN-2-ONE DERIVATIVES Merck Patent GmbH (DE) 2018-11-21 — — EP disclosed
WO-2017121444-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2017-07-20 — — WO disclosed
WO-2017121444-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2017-07-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174241-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 MAPK14 665/4885PIK3CA 217/4885CSNK1D 47/4885
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 MAPK14 665/4885PIK3CA 217/4885CSNK1D 47/4885
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 MAPK14 665/4885PIK3CA 217/4885CSNK1D 47/4885
US-11939314-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 MAPK14 665/4885PIK3CA 217/4885CSNK1D 47/4885
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 MAPK14 665/4885PIK3CA 217/4885CSNK1D 47/4885
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 MAPK14 665/4885PIK3CA 217/4885CSNK1D 47/4885
US-10669251-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 MAPK14 665/4885PIK3CA 217/4885CSNK1D 47/4885
US-11186562-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 MAPK14 665/4885PIK3CA 217/4885CSNK1D 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback